Introduction and Definitions

1. Introduction

We process personal data for the operation of our website avicenna-alliance.com (hereinafter referred to as “Website”). We keep such data in confidence and process them in accordance with the applicable laws – in particular, the General Data Protection Regulation (GDPR). In this Privacy Policy, we wish to inform you about which personal data we collect from you, for which purposes and on which legal basis they are used and to whom we disclose them, if appropriate. Furthermore, we will explain which rights you have to protect and enforce your rights for data protection.

2. Definition of Terms

Our Privacy Policy contains technical terms which are defined in the GDPR and the BDSG-new. For your better understanding, we will explain these terms in a more simplified way:

2.1 Personal data
“Personal data” means any information relating to an identified or identifiable natural person (Art. 4(1) of the GDPR). Data of an identified person might be, for instance, their name or email address. Data, however, might also be personal if the identity is not directly recognisable but could be determined by combining own or external information in order to identify that person. A person is identifiable, if information is available about, e.g. their address or bank details, their date of birth or user name, their IP address and/or location data. This means that here any information is relevant which allows for any type of conclusion to be drawn on a person.

2.2 Processing
Art. 4(2) of the GDPR provides that “processing” means any operation which is performed on personal data. That means, in particular, the collection, recording, organisation, structuring, storage, adaptation or alteration, retrieval, consultation, use, disclosure, transmission, dissemination or otherwise making available, alignment or combination, restriction, erasure or destruction of personal data.

Controller and Data Protection Officer

3. Controller

The following company is responsible for data processing and thus the controller:

Company: Avicenna Alliance – Association for Predictive Medicine ("we")
Legal representative: Avicenna Alliance – Association for Predictive Medicine
Address: Rue Guimard 10, 1040 Brussels
Email: secgen@avicenna-alliance.com

Framework of processing

4. Framework of processing: Website

We will process the personal data listed in detail under Art. 5-7 below, when you use the Website with the URL avicenna-alliance.com. In this process, we will only process data from you that you actively enter on our Website (e.g. by completing forms) or that you provide automatically when using our offer.

Your data will exclusively be processed by us and these data will, as a matter of principle, not be sold, leased or provided to any third parties. Insofar as we use external service providers for the processing of your personal data, that will be done in the context of a cooperation with a so-called data processor, where we act as principal and are authorised to give instructions to our contractors. For the operation of our Website, we use external service providers for hosting, and for the maintenance, update and further development. Insofar as other external service providers will be used for individual processing activities that are listed in Art. 5-7, they will be specified there.

We do, in general, not transfer any data to any third countries and this is not planned for the future either. Any exemptions from this principle will be explained in the types of processing activities listed below.

The processing activities in detail

5. Provision of the Website and Log Files

5.1 Description of processing
Whenever anybody visits our Website, we automatically collect information that their browser transfers to our server. These data will also be stored in the so-called log files of our system. This concerns the following data:

  • Your IP address will be shortened and exclusively the last three places will be stored in the log files.

5.2 Purpose
The processing is done to allow for the Website to be called and to ensure its stability and security. In addition, the processing serves for statistical analyses and the improvement of our online offer.

5.3 Legal basis
The processing is necessary for the purposes of the legitimate interests pursued by the controller (Art. 6(1) point (f) of the GDPR). Our legitimate interest is the purpose mentioned in Art. 6.2.

5.4 Storage duration
The data will be erased once they are no longer required to achieve the purpose of their collection. If data are collected to provide the Website, they will be erased once the respective session has been terminated. The log files will be erased after 30 days.

6. Contact form and contact by email

6.1 Description of processing
We provide you with a contact form on our Website which you can use to contact us. In this form, you will be asked to enter your email address, your name and a message. When clicking the “Send” button, the data will be transferred to us by using SSL encryption (see Art. 12). The contact form can only be transferred if you accept our Privacy Policy by clicking the check box provided. You may also contact us by using the email address specified on our Website. In this case, we will process the personal data of the user that were transferred with the email.

6.2 Purpose
The contact form provided on our Website should offer you a convenient option to contact us. The data transferred with and in the contact form or your email will exclusively be used for the purpose of handling and answering your request.

6.3 Legal basis
The processing is necessary for the purposes of the legitimate interests pursued by the controller (Art. 6(1) point f) of the GDPR). Our legitimate interest is the purpose mentioned in Art. 7.2. Insofar as the contact by email is aimed at concluding or performing a contract, the data will be processed to perform a contract (Art. 6(1) point b) of the GDPR).

6.4 Storage duration
We will erase the data, as soon as such are no longer required to achieve the purpose of their collection. That is usually the case when the relevant communication with you has been terminated. The communication is deemed terminated as soon as the circumstances reveal that the relevant issue has been conclusively resolved. Insofar as any statutory retention period conflicts with the erasure, the data will be erased immediately after the expiry of the statutory retention period.

7. Cookies

7.1 Description of processing
Our Website uses cookies. Cookies are small text files which are stored in the user’s end device when they visit a website. Cookies contain information which allow for the recognition of a device or enable certain functions of a website. We mostly only use so-called “session cookies”. These will automatically be erased when you end your internet session and close the browser. Other cookies will remain on your device for a longer period of time. We use the cookies set out below on our Website:

_ga (Provider: pancreaticcancereurope.eu)
Function: Registers unique ID that is used to generate statistical data about how the visitor uses the site.
Storage time: 2 years

_gat (Provider: pancreaticcancereurope.eu)
Function: Used by Google Analytics to limit the request rate.
Storage time: This cookie expires at the end of the browser session.

_gid (Provider: pancreaticcancereurope.eu)
Function: Registers unique ID that is used to generate statistical data about how the visitor uses the site.
Storage time: This cookie expires at the end of the browser session.

collect (Provider: google-analytics.com)
Function: Marketing cookie to follow users on websites.
Storage time: This cookie expires at the end of the browser session.

7.2 Purpose
We use cookies to make our Website more user-friendly and to offer the functions described in Art. 10.1.

7.3 Legal basis
The processing is necessary for the purposes of the legitimate interests pursued by the controller (Art. 6(1) point f) of the GDPR). Our legitimate interest is the purpose mentioned in Art. 10.2.

7.4 Storage duration
Cookies will automatically be deleted at the end of a session and upon expiry of the storage duration specified. Since cookies are stored on your device, you as user have full control over the use of cookies. By changing the settings in your internet browser, you can deactivate or restrict the transfer of cookies. Cookies already stored can be deleted at any time. This can also occur automatically. If you deactivate cookies for our Website, you may be unable to use individual functions of our Website or such might be used in a restricted way only.

 

8. Social Networks

Our Website uses none of the so-called social media plug-ins. The logos of the social networks Facebook and Twitter displayed on our Website are linked only with the relevant profiles of our company. When you click on one of the logos, you will reach the external websites of those social networks.

9. Google Maps

9.1 Description of processing
Our Website uses “Google Maps,“ a service for displaying maps provided by the company Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA (hereinafter referred to as “Google“). We use Google Maps for embedding a map that displays our business address in our Website. The map will be loaded directly from a Google server. In order to do this, your browser will send a request to a Google server. Your IP address might also be transferred to Google together with the address of our Website. Google Maps will, however, not store any cookies on your device. If you are logged in to Google when you visit our Website, Google Maps will associate this information to your Google user account. Google will store your data as user profiles and will use them for marketing purposes, for market research and/or the customised configuration of the Google websites. You have a right to object against the creation of user profiles; please directly contact Google to exercise such right. For more information on data privacy at Google, please refer to http://www.google.com/intl/de-DE/policies/privacy/.

9.2 Purpose
The processing is done to be able to display an interactive map on our Website.

9.3 Legal basis
The processing is necessary for the purposes of the legitimate interests pursued by the controller (Art. 6(1) point f) of the GDPR). Our legitimate interest is the purpose mentioned in Art. 19.2.

9.4 Recipients and transfer to third countries
Google processes your personal data also in the U.S. and has agreed to comply with the EU-US Privacy Shield. For more information on the EU-US Privacy Shield, please refer to https://www.privacyshield.gov/EU-US-Framework.

10. Google Analytics

10.1 Description of processing
Our Website uses “Google Analytics”, a web analysis service provided by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA (hereinafter referred to as “Google”). Google Analytics uses cookies (see Art. 7), which allow for an analysis of your use of our offer. We use Google Analytics in the version offered as “Universal Analytics” which allows for this analysis across devices by allocating the data to a pseudonymised user ID. The information created by the cookie are generally transferred to a Google server in the U.S. and stored there. But, we use Google Analytics exclusively with IP anonymisation. This means that your IP address will be shortened by Google within the European Union member states or other states which are part of the European Economic Area before it is transmitted. Only in exceptional cases will the full IP address be transmitted to a Google server in the U.S. and shortened there. The IP address transferred by your browser in the context of Google Analytics will not be combined with any other data from Google. The statistics created by Google Analytics record, in particular, how may users visit our Website, from which country or place they access the Website, which sub-pages they visit and through which links or search terms visitors come to our Website. For the terms of use for Google Analytics please visit www.google.com/analytics/terms/gb.html. An overview of the data privacy at Google Analytics can be retrieved from http://www.google.com/intl/en/analytics/learn/privacy.html. You can see Google’s data privacy policy at http://www.google.de/intl/en/policies/privacy.

10.2 Purpose
The processing is done to be able to evaluate the use of our Website. The information gained in the process serve to improve our online presentation and to design it according to demand.

10.3 Legal basis
The processing is necessary for the purposes of the legitimate interests pursued by the controller (Art. 6(1) point f) of the GDPR). Our legitimate interest is the purpose mentioned in Art. 20.2.

10.4 Storage period and right to object
For information on the storage period and an explanation of your control and setting options for cookies, please refer to Art. 7. You may object to the data processing by Google Analytics, at any time, by downloading and installing the browser add-on offered by Google at https://tools.google.com/dlpage/gaoptout?hl=en. Alternatively, you have the option to click on the following link. This will place an opt-out cookie on your device which prevents the future collection of your data when visiting this Website.

Disable Google Analytics

We will automatically delete any analysis data processed and stored by Google Analytics after 14 months.

10.5 Recipients and transfer to third countries
Google Analytics is active for us as service provider in the capacity of a processor. Google processes your personal data also in the U.S. and has agreed to comply with the EU-US Privacy Shield. For more information on the EU-US Privacy Shield, please refer to https://www.privacyshield.gov/EU-US-Framework.

11. Google reCAPTCHA

11.1 Description of processing
Our Website uses “reCAPTCHA”, a service provided by Google Inc., 1600 Amphitheatre Parkway, Mountain View, California 94043, USA (hereinafter referred to as “Google“). reCAPTCHA allows us to verify in forms whether the entry was made by a human or by an automated software – in particular, so-called bots. This enables us to protect our Website against spam and abuse. In this process, your IP address, the time you visited our Website, the mouse movements you made and other data required for the reCAPTCHA services might be transferred to Google. For more information on data privacy at Google, please refer to http://policies.google.com/privacy.

11.2 Purpose
The processing is done to protect forms on our Website against abuse and spam.

11.3 Legal basis
The processing is necessary for the purposes of the legitimate interests pursued by the controller (Art. 6(1) point f) of the GDPR). Our legitimate interest is the purpose mentioned in Art. 26.2.

11.4 Recipients and transfer to third countries
Google processes your personal data also in the U.S. and has agreed to comply with the EU-US Privacy Shield. For more information on the EU-US Privacy Shield, please refer to https://www.privacyshield.gov/EU-US-Framework.

Security measures

12. Security measures

We integrated a SSL or TLS certificate in our Website to protect your personal data against unauthorised access. SSL means “Secure Sockets Layer” and TLS means “Transport Layer Security” and encrypts the communication of data between a website and the user’s computer. You recognise active SSL and TLS encryption by the small lock logo displayed on the left side of your browser’s address line.

Your rights

13. Rights of data subjects

You, as data subject, have the following rights in view of the data processing performed by our company as described above:

13.1 Right of access (Art. 15 of the GDPR)
You have the right to obtain confirmation from us as to whether or not personal data concerning you are being processed by us. Where that is the case, you have a right of access to the personal data under the conditions set out in Art. 15 of the GDPR and the other information specified in detail in Art. 15 of the GDPR.

13.2 Right to rectification (Art. 16 of the GDPR)
You have the right to obtain from us, without undue delay, the rectification of inaccurate personal data concerning your person and, if necessary, the right to have incomplete personal data completed.

13.3 Right to erasure (Art. 17 of the GDPR)
You also have the right to obtain from us the erasure of personal data concerning you without undue delay, insofar as one of the grounds listed in Art. 17 of the GDPR applies, e.g. if the data is no longer required in relation to the intended purpose.

13.4 Right to restriction of processing (Art. 18 of the GDPR)
You have the right to obtain from us restriction of processing where one of the conditions listed in Art. 18 of the GDPR applies, e.g. if the accuracy of the personal data is contested by you, the data processing will be restricted for a period enabling us to verify the accuracy of the personal data.

13.5 Right to data portability (Art. 20 of the GDPR)
You have the right to receive the personal data concerning you under the preconditions set out in Art. 20 of the GDPR in a structured, commonly used and machine-readable format.

13.6 Right to withdrawal of consent (Art 7(3) of the GDPR)
You shall have the right to withdraw your consent, at any time, for processing which is based on your consent. The withdrawal of your consent will apply from the time it is made. In other words, it will apply for the future. The withdrawal of consent shall not affect the lawfulness of processing based on consent before its withdrawal.

13.7 Right to lodge a complaint (Art. 77 of the GDPR)
If you consider that the processing of personal data relating to you infringes the GDPR, you have the right to lodge a complaint with a supervising authority. You may exercise this right with a supervisory authority in the EU Member State of your habitual residence, place of work or place of the alleged infringement.

13.8 Prohibition of automated decision-making / profiling (Art. 22 of the GDPR)
Decisions which produce legal effects concerning you or similarly significantly affect you must not be subject to a decision based solely on automated processing – including profiling. We hereby inform you that we use no automated decision-making, including profiling, in view of your personal data.

13.9 Right to object (Art. 21 of the GDPR)
When we process personal data concerning you on the basis of Art. 6(1) point f) of the GDPR (for the purposes of the legitimate interests), you have the right to object under the grounds set out in Art. 21 of the GDPR. This, however, shall apply only on grounds relating to your particular situation. After your objection, we will no longer process your personal data, unless we are able to demonstrate compelling legitimate grounds for processing which override your interests, rights and freedoms. We also do not need to stop the processing, if it serves for the establishment, exercise or defence of legal claims. In each case – even regardless of a special situation – you have the right to object against the processing of your personal data for direct marketing, at any time.

Version: July 2018

Avicenna Alliance news

Welcome to our new member MDsim!

We are delighted to welcome our new member MDsim!

MDsim is a health-tech start-up, based in Luxembourg, active in the In-Silico Medicine. 

find out more ›

Mapping the use of computational modelling and simulation in clinics: A survey

Computational modelling and simulation (CM&S) can be used in medicine to mimic biological processes with the goal of...

find out more ›

Nathalie Virag is the new Avicenna International Affairs Working Group Leader!

Nathalie Virag, Ph.D is a Distinguished Scientist at Medtronic Corporate Technology & Innovation. She has more than 25...

find out more ›

Second release of Avicenna Glossary now available!

This Glossary is a second release with an extended list of definitions; more concepts will be defined and existing definitions may be adjusted in...

find out more ›

We are delighted to welcome France Biotech as a new Avicenna Partner

Founded in 1997, France Biotech is an independent association, uniting the country’s leading innovative health companies and their...

find out more ›

The potential of in silico approaches to streamline drug development

This position paper highlights the potential of in silico medicine, using computational modelling and simulation to aid drug...

find out more ›

DON'T LOOSE THE AVICENNA DAYS 2023 !!!

We will give the entire healthcare community an exhaustive update on recent progress and achievements related to the adoption and deployment of in silico method...

find out more ›

Avicenna Alliance Observer at IMDRF meeting in Brussels

The Avicenna Alliance had received the honor to be invited as an Observer to the International Medical Device Regulators Forum (IMDRF) meeting...

find out more ›

Avicenna Alliance meets with MEPs in Strasbourg

During the European Parliament’s plenary session that took place in the second week of March, Avicenna had the unique opportunity to visit the European...

find out more ›

Welcome RBF Morph!

Welcome to our new member RBF Morph! Based in Monte Compatri, Rome, RBF is a pioneer and leader in mesh morphing, a key technology used in engineering simulation.

find out more ›

Mimesis is a new Avicenna member!

We are truly delighted to welcome Mimesis as a new Avicenna member!

Mimesis is an innovative start-up, founded in 2020 as a spinoff of the University of Catania,...

find out more ›

Shiny Martis is the new Pharmaceutical Strategy TF Co-Chair

We are delighted to welcome Shiny Martis as the new Pharmaceutical Strategy TF Co-Chair.

Shiny is Academic Partnership and Customer...

find out more ›

Numalogics is a new Avicenna member

We are honored to welcome Numalogics as a new Avicenna’s member!
Numalogics is a Montréal-based privately held company priding itself on its world-class...

find out more ›

Congratulations to our new Working Group Leaders!

We are delighted to welcome Cécile Rousseau and Martha De Cunha who have been elected as new Working Group Leaders of the Avicenna's 

In Silico... find out more ›

In Silico Application (ISA) Working Group

Digital evidence can and must be used for regulatory approval in all parts of the world. The Research & Technology Working Group has made huge progress,...

find out more ›

Working Group Leaders elections

Our warmest congratulations to Liesbet Geris and Mark Palmer for their reappointment as Working Group Leaders of the Avicenna's Research & Technology Working Group and...

find out more ›

We are delighted to welcome NumeriCor as a new Avicenna member!

NumeriCor is a leading cardiac electrophysiology and mechanics modelling company providing end-to-end simulation control. 

find out more ›

Avicenna Alliance Glossary of Terms for Computer Modeling and Simulation

There are occasional confusions and diverging opinions possibly leading to misunderstanding in the use of some In Silico...

find out more ›

THE ROLE OF ARTIFICIAL INTELLIGENCE WITHIN IN SILICO MEDICINE

A range of authors across academia and industry, representing both the Avicenna Alliance and the Virtual Physiological Human Institute,...

find out more ›

Toward a regulatory pathway for Using in Silico Trials in CE Marking of Medical Devices

 

A team of researchers of the In Silico World project, including several key Avicenna Alliance members, led...

find out more ›

Avicenna Alliance response to the ICHE11A Consultation

The Avicenna Alliance strongly supports and welcomes the ICH’s proposed goal of harmonizing methods and strategies for improved paediatric drug...

find out more ›

Avicenna Alliance Feedback to the European Health Data Space Call for Feedback

The Avicenna Alliance welcomes the proposal for the EHDS. The Alliance is a multistakeholder group with the mission of...

find out more ›

We are honored to welcome Zimmer Biomet as a new Avicenna’s member!

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve...

find out more ›

Avicenna Alliance Response to 2023 Stakeholders' Targeted Consultation on EU4Health

The Avicenna Alliance stressed the need for further support and guidance for digital evidence from in silico...

find out more ›

New Avicenna APAC Task Force

A new Task Force joined the International Affairs Working Group!

find out more ›

Cécile De Coster is the new Avicenna Pharmaceutical Strategy Task Force Co-chair

We are proud to welcome Cécile De Coster as the new Avicenna Pharmaceutical Strategy Task Force co-chair!

find out more ›

Avicenna Alliance goes on growing by welcoming Edwards Lifesciences as a new member!

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and...

find out more ›

Avicenna Alliance is honoured to welcome Alfasigma as a new member!

Privately owned, Alfasigma is one of the leading Italian pharmaceutical companies, present in over 90 countries, through...

find out more ›

EU-funded project successfully develops AI software that grows and treats cancerous tumors 

The Horizon Europe 2020 project EVO-NANO (Evolvable platform for programmable nanoparticle-based cancer...

find out more ›

In silico used to validate Omicron variant detection method! 

The Joint Research Centre (JRC) has developed a new method to detect the Omicron variant of COVID-19, which differs in its nucleic acid...

find out more ›

The priorities of the upcoming French Presidency of the Council of the European Union - what’s new for Avicenna? 

The French Presidency of the Council of the European Union is due to start on 1...

find out more ›

New Avicenna UK Insilico Regulatory Innovation Task Force

The Avicenna International Affairs Working Group adds a new task force to its structure.

find out more ›

In Silico in Innovation – again!

The European Innovation Council (EIC) has released its second wave of “start-up champions” to receive funding for innovations through the EIC Accelerator. The EIC...

find out more ›

Avicenna Alliance meets with MEPs to discuss in silico medicine

On 7 October, Dr. Liesbet Geris (Research Professor in Biomechanics and Computational Tissue Engineering at the Universities of Liège &...

find out more ›

The Joint Research Centre advocates for a “paradigm change” to in silico research methods!

For the second week in a row, the Joint Research Centre (JRC) – part of the European Commission’s EU Science...

find out more ›

The European Commission Joint Research Centre publishes a public knowledge base of non-animal models used in immuno-oncology

The Joint Research Centre (JRC), which is part of the European...

find out more ›

The State of the (European) Union

On 15 September, Commission President Ursula von der Leyen delivered her second State of the Union speech at the European Parliament in Strasbourg. She took stock of...

find out more ›

The BECA Beat 

The European Parliament’s Special Committee on Beating Cancer (BECA) met for the first time in September of 2020. BECA was established to create actionable recommendations for Member...

find out more ›

Avicenna Alliance prepares for the next EU policy session 

As September begins, politicians have returned to their EU posts and are preparing for what will be a busy few months for health policy. The...

find out more ›

Joint Research Centre of the Commission launches report on national strategies for Artificial Intelligence!

The Joint Research Centre of the European Commission (JRC) recently published a new report...

find out more ›

Conference of the Slovenian Council Presidency addresses digital twin technologies and digitalisation in healthcare!

On 15 and 16 July, the Slovenian Presidency of the Council of the European Union ...

find out more ›

WHO issues first global report on use of AI in healthcare

Artificial Intelligence (AI) applications in health innovation are rapidly increasing, reflecting the potential of these technologies to...

find out more ›

Slovenian Presidency of the Council of the EU launches its six-month programme!

On 1 July, for the second time since joining the EU in 2004, Slovenia has taken over the Presidency of the Council of...

find out more ›

Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!

On 22 June, a group of five Members of the European Parliament...

find out more ›

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

<link...</h3>

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up